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IMPORTANCE Few studies have examined how different proportions of moderate and
vigorous physical activity affect health outcomes.
OBJECTIVE To examine whether the proportion of total moderate to vigorous activity (MVPA)
that is achieved through vigorous activity is associated with all-cause mortality independently
of the total amount of MVPA.
DESIGN, SETTING, AND PARTICIPANTS Weperformed a prospective cohort studywith activity
data linked to all-cause mortality data from February 1, 2006, through June 15, 2014, in
204 542 adults aged 45 through 75 years from the 45 and Up population-based cohort study
fromNew SouthWales, Australia (mean [SD] follow-up, 6.52 [1.23] years). Associations
between different contributions of vigorous activity to total MVPA andmortality were
examined using Cox proportional hazards models, adjusted for total MVPA and
sociodemographic and health covariates.
EXPOSURES Different proportions of total MVPA as vigorous activity. Physical activity was
measured with the Active Australia Survey.
MAIN OUTCOMES ANDMEASURES All-causemortality during the follow-up period.
RESULTS During 1 444 927 person-years of follow-up, 7435 deaths were registered.
Compared with those who reported noMVPA (crude death rate, 8.34%), the adjusted hazard
ratios for all-cause mortality were 0.66 (95% CI, 0.61-0.71; crude death rate, 4.81%), 0.53
(95% CI, 0.48-0.57; crude death rate, 3.17%), and 0.46 (95% CI, 0.43-0.49; crude death rate,
2.64%) for reporting 10 through 149, 150 through 299, and 300min/wk or more of activity,
respectively. Among those who reported anyMVPA, the proportion of vigorous activity
revealed an inverse dose-response relationship with all-cause mortality: compared with those
reporting no vigorous activity (crude death rate, 3.84%) the fully adjusted hazard ratio was
0.91 (95% CI, 0.84-0.98; crude death rate, 2.35%) in those who reported some vigorous
activity (but <30% of total activity) and 0.87 (95% CI, 0.81-0.93; crude death rate, 2.08%)
among those who reported 30% ormore of activity as vigorous. These associations were
consistent in men and women, across categories of bodymass index and volume of MVPA,
and in those with and without existing cardiovascular disease or diabetes mellitus.
CONCLUSIONS AND RELEVANCE Among people reporting any activity, there was an inverse
dose-response relationship between proportion of vigorous activity andmortality. Our
findings suggest that vigorous activities should be endorsed in clinical and public health
activity guidelines to maximize the population benefits of physical activity.
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N umerous studies1,2 have found that physical activitydecreases the risk of many chronic diseases and in-creases longevity. On the basis of epidemiologic and
clinical studies,3 current US,4 UK,5 Australian,6 and World
HealthOrganization7guidelines suggest that significanthealth
benefits can accrue through accumulationof at least 150min-
utes of moderate activity (3-5.9 metabolic equivalent tasks
[METs]) or 75 minutes of vigorous activity (≥6 METs) or an
equivalent combination of moderate and vigorous activities
where “2 minutes of moderate-intensity activity counts the
same as 1 minute of vigorous-intensity activity.”4 Implicit in
these guidelines is that these amounts of moderate and vig-
orous activity confer similar benefits, but this remains
unclear.8-15
Independent of energy expenditure, vigorous physical ac-
tivity is more efficient thanmoderate activity in inducing car-
diorespiratoryandmetabolic fitness,16-21which isastrongerpre-
dictorofmorbidityandmortality thanactivity.3,9,22,23Therefore,
it couldbehypothesized that theremightbegreaterhealthben-
efits fromvigorousactivity thanfrommoderateactivitiesalone,
evenwhen the overall amount of activity is held constant.
Therehavebeencalls formore research toexamine the role
of activity intensity forhealthbenefits.3,13,24-28However, indo-
ing this, it is important to account for the potential confound-
ing of the total amount of activity because lower risk attrib-
uted to vigorous activities may simply reflect higher total
energy expenditure.24 Systematic reviews and meta-
analyses have concluded that self-reported activity intensity
is abetterpredictorofmortality than total amountof activity26
and that vigorous activity provides more benefit in reducing
mortality risk thanmoderate activity.8However, Powell et al14
noted that several of these studiesdidnot control for theover-
all amount of activity.
On the basis of a large Australian cohort, the aim of the
present studywas to examinewhether theproportionof total
moderate tovigorousphysical activity (MVPA) that is achieved
through vigorous activity is associatedwith all-causemortal-
ity, independently of the total amount of MVPA. We hypoth-
esized that, among those reporting anyMVPA, higher propor-
tionsof vigorousactivitywouldbeassociatedwitha lower risk
of all-cause mortality.
Methods
Study Population
The Sax Institute’s 45 and Up study is a large prospective co-
hort study of men and women from the general population of
the stateofNewSouthWales,Australia. Thebaselinedatawere
collected in 2006-2009 (n = 267 153). Individuals 45 years and
older were randomly sampled from theMedicare Australia da-
tabase, throughwhichnationalhealth care is administeredand
includes all citizens and permanent residents of Australia and
sometemporary residentsandrefugees.Eligible individuals re-
ceivedamailedinvitationtoparticipatewithaninformationleaf-
let, the studyquestionnaire, a consent form (including consent
for long-term follow-up by linking their data to data from a va-
rietyofpopulationdatabases),andaprepaidenvelope.Theover-
all participation rate to themailed invitations to join the45 and
Upstudywasestimated tobe 18%, similar toother cohort stud-
ies of this kind.29,30 However, it is difficult to specify the exact
participation rate because some peoplemay not have received
the invitations if theiraddressdetailswere incorrect intheMedi-
careAustraliadatabase.31Approximately10%ofthewholepopu-
lation of New SouthWales 45 years and older were included in
the final sample.32Amoredetaileddescriptionof the45andUp
studyhasbeenprovidedelsewhere.31 Participantsolder than75
years (n = 45 211)were excluded from this analysis because the
main outcome of interest was preventable deaths at an earlier
age. Those with missing values for physical activity (n = 2850)
were excluded from the analysis examining the association be-
tween total MVPA volume and mortality (n = 217 755). For in-
vestigatingtheassociationbetweentheproportionoftotalMVPA
byvigorous activity,we further excluded thosewhodidnot re-
portanyactivity (n = 13 213), resulting inafinalanalyticalsample
size of 204 542 participants. Those with no MVPA were ex-
cluded from the latter analysis because we could not calculate
a percentage of MVPA that was vigorous because the denomi-
natorwould have been zero. The present projectwas approved
by the New South Wales Population and Health Services Re-
search Ethics Committee.
Variables
Self-reported data were used from the baseline question-
naire (http://www.45andUp.org.au). Moderate to vigorous
physical activitywasmeasuredwith itemsfromtheActiveAus-
tralia Survey,33 which asks participants about sessions (bouts
of at least 10minutes) anddurationofwalking,moderate, and
vigorous activity in the past week. In the questionnaire, vig-
orous activity is defined as activity “that made you breathe
harder or puff and pant, like jogging, cycling, aerobics, com-
petitive tennis, but not household chores or gardening.” For
moderate activity examples “likegentle swimming, social ten-
nis, vigorous gardening or work around the house” are pro-
vided. This instrument has acceptable reliability (coeffi-
cients forwalking,moderate andvigorous activity frequency,
and time ranging from 0.56 to 0.64) and validity (correlation
of duration of self-reported activity with accelerometer data
was0.52).34,35Aswell, apreviousstudy36 foundthat in theAus-
tralianadult population theActiveAustralia surveyhadhigher
reliability and validity than the International Physical Activ-
ityQuestionnaire and theCenters forDiseaseControl andPre-
vention Behavioral Risk Factor Surveillance System survey.
Minutes per week of walking and MVPA (vigorous activity
weighted by 2)33 were summed to create a total weighted
amount of MVPA. The proportion of MVPA that was attribut-
able to vigorous activity was calculated (vigorous activity
× 2/weighted MVPA × 100%). Covariates included age, sex,
educational level,marital status,urbanor rural residence,body
mass index (BMI; calculated as the weight in kilograms
divided by height in meters squared), physical function,
smoking status, alcohol consumption, fruit and vegetable
consumption, and MVPA. The BMI was derived from self-
reportedmeasures ofweight and height, which had excellent
agreement with objectively measured BMI categories in a
subsample of 45 and Up.37 Physical function was mea-
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suredwith the10-itemMedicalOutcomesStudyPhysicalFunc-
tioning scale, which has good reliability and validity.38,39 All-
causemortalitywas based ondata from theNewSouthWales
RegistryofBirths,Deaths,andMarriages fromFebruary1,2006,
through June 15, 2014. The mortality data were linked to the
baseline data from45 andUp by the Centre for Health Record
Linkage using probabilistic record linkagemethods and com-
merciallyavailable software (ChoiceMaker,ChoiceMakerTech-
nologies Inc).Manual clerical reviewwas performed to check
indeterminatematches.Evaluationof theaccuracyof theover-
all linkage was determined by clerical review of samples of
matched records.
Statistical Analysis
Cox proportional hazards regressionmodels were used to ex-
amine the association of the proportion of total MVPA re-
ported as vigorous activity with all-cause mortality. Survival
time was measured as the time from the baseline survey to
death or the censor point (June 15, 2014). TotalMVPAwas cal-
culated using the guidelines provided for Active Australia
questions33 and then categorized as 0, 10 to 149, 150 to 299,
and 300 min/wk or more. Among those reporting any physi-
cal activity, 3 categories were used for the percentage of total
MVPA thatwas vigorous: no vigorous activity (0%), somevig-
orous activity (>0% to <30%), and 30%ormore of totalMVPA
as vigorous activity. The 30% cutoff point was based on care-
ful inspection of the data distribution and on plotting the as-
sociationbetweenthepercentageofvigorousactivityandmor-
tality using a segmented regression model, where the
magnitude of association changed substantially when vigor-
ous activity reached approximately 30%.
All Cox proportional hazards models were adjusted for
baseline age, sex, educational level, marital status, urban or
rural residence, BMI, smoking status, physical function, alco-
hol consumption, fruit and vegetable consumption, and total
MVPA. Regression models were repeated stratified by sex,
weight status (obese vs nonobese), volumeofMVPA, and car-
diometabolic diseases (based on reported diagnosis by a phy-
sicianofheart disease, stroke, thrombosis, anddiabetesmelli-
tus). We examined effect modification by age, sex, weight
status (obesevsnonobese), amountofMVPA, andchronicdis-
ease, using likelihood ratio tests to comparemodels with and
without an interaction term. Further stratified analyses were
conducted tocompare themodelsofeachsubsample.Tomaxi-
mize statisticalpower,participantswithmissingvalues for any
covariate were assigned to a separate category for that vari-
able. Toaccount forpotential confounding throughoccult dis-
ease at baseline, the analyses were repeated excluding those
who died in the first year of follow-up. All analyseswere con-
ducted using SAS statistical software, version 9.3 (SAS Insti-
tute Inc).
Results
Descriptive Statistics
Descriptive statistics of the sample are presented in Table 1.
Of the 217 755 participants 55.2% were women, 63.8% were
overweight or obese, 25.5% had completed a university de-
gree, 78.3%metminimalactivity recommendations, and62.1%
met thenewAustralianhigh active recommendation40 of 300
min/wkormoreofactivity.Of thosewhoreportedsomeMVPA,
more than half (55.3%) did not report any vigorous activity,
16.3% reportedmore than 0% to less than 30%, and 28.4% re-
ported 30% or more of their total MVPA as vigorous activity.
Younger, better educated, and male participants were more
likely to report 30% or more of their MVPA as vigorous activ-
ity, and those with underweight or obese BMI and with poor
physical function scores were less likely to report this.
In Table 2, death rates among those who reported any
MVPA are given by levels of activity and by the proportion of
MVPA as vigorous activity. There was an inverse association
between total MVPA and crude death rates, and within each
volumecategory (10-149 [notmeetingguidelines], 150-299,and
≥300 min/wk), there was an inverse association between the
percentageofvigorousactivityandcrudedeathrates.For those
who did not meet guidelines and for the most active partici-
pants, 30%ormoreofMVPAasvigorous activity conferred the
most benefit.
Proportion of Total Activity as Vigorous Activity
and All-CauseMortality
During 1 444 927person-yearsof follow-up (mean [SD] follow-
up, 6.52 [1.23] years), 7435 deaths were registered. Compared
with those who reported no MVPA, the adjusted hazard ra-
tios for all-causemortality were 0.66 (95% CI, 0.61-0.71), 0.53
(95% CI, 0.48-0.57), and 0.46 (95% CI, 0.43-0.49) for report-
ing 10 through 149, 150 through 299, and for 300 min/wk or
more of activity, respectively. Among thosewho reported any
MVPA, compared with those who did not report any vigorous
activity, the adjusted hazard ratios for all-cause mortality
were 0.91 (95% CI, 0.84-0.98) and 0.87 (95% CI, 0.81-0.93) for
more than 0% to less than 30% and for 30% or more of total
MVPA time achieved by vigorous activity, respectively. The
association between the proportion of MVPA as vigorous
activity and all-cause mortality was consistent across age
groups, sexes, activity levels, obese and nonobese partici-
pants, and participants with and without existing cardio-
metabolic disease (there were no statistically significant
interactions at P < .05) (Table 3).
Discussion
In this large sampleofmiddle-agedandolder adults,we found
that among those who reported any physical activity, engag-
ing invigorous activitywas associatedwith risk reductions for
mortalityof9%to13%,evenafteradjusting for thetotalamount
of activity. This finding is in line with other studies41-43 that
have reported significant benefits of vigorous activity in re-
ducingmortality. In thismiddle toolderadultpopulation, these
findings suggest that even small amounts of vigorous activity
may supplement the benefits ofmoderate activity alone. Our
findingsare in linewiththose fromUScohort studies that found
that independentof activity volume, activity intensitywas as-
sociatedwith reduced risk of coronaryheart disease44 andall-
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cause mortality in men.45 Moreover, a meta-analysis46 con-
cluded that walking pace, rather than time spent walking, is
associated with longevity.
A literature review27 concluded that, although moderate
activity reduces cardiovascular risk, higher-intensity activi-
tiesprovideevenmorecardioprotection.Otherclinical andepi-
demiologic studies have also found that, adjusted for activity
amount, higher proportions of vigorous activity are benefi-
cial for cardioprotection,17,44metabolic health,17,21 andmain-
tenance of physical function.47
In the present study, the protective effect of vigorous ac-
tivity against mortality applied across age groups, sexes, ac-
Table 1. Characteristics of 217 755 Participants of 45 and Up, 2006-2009, by the Proportion ofWeighted Total
MVPAVolume as Vigorous Activitya
Variable
No. (%) of Participants
Total No. of
ParticipantsNo MVPA
Vigorous Activity
0% >0% to <30% ≥30%
Total 13 213 (6.1) 113 181 (52.0) 33 371 (15.3) 57 990 (26.6) 217 755
Sex
Female 7364 (6.2) 65 997 (55.2) 17 721 (14.8) 28 439 (23.8) 119 521
Male 5849 (6.0) 47 184 (48.0) 15 650 (15.9) 29 551 (30.1) 98 234
Age group, y
45-54 4217 (5.5) 34 232 (44.8) 12 131 (15.9) 25 848 (33.8) 76 428
55-64 4959 (5.9) 44 078 (52.4) 13 584 (16.1) 21 553 (25.6) 84 174
65-75 4037 (7.1) 34 871 (61.0) 7656 (13.4) 10 589 (18.5) 57 153
Educational level
High school or
less (low)
6058 (8.9) 40 269 (59.1) 8083 (11.9) 13 734 (20.2) 68 144
Middle 5035 (5.5) 47 373 (51.5) 14 937 (16.2) 24 709 (26.8) 92 054
Completed
university (high)
1800 (3.3) 24 108 (43.9) 10 082 (18.3) 18 987 (34.5) 54 977
Missing 320 (12.4) 1431 (55.5) 269 (10.4) 560 (21.7) 2580
Marital status
Married de facto 9729 (5.8) 86 956 (51.5) 26 642 (15.8) 45 592 (27.0) 168 919
Other 3371 (7.1) 25 667 (53.9) 6565 (13.8) 12 048 (25.3) 47 651
Missing 113 (9.6) 558 (47.1) 164 (13.8) 350 (29.5) 1185
Location of
residence
Rural 4477 (6.7) 34 881 (52.5) 10 831 (16.3) 16 207 (24.4) 66 396
Urban 8732 (5.8) 78 228 (51.7) 22 508 (14.9) 41 721 (27.6) 151 189
Missing 4 (2.4) 72 (42.4) 32 (18.8) 62 (36.5) 170
Smoking status
Never 6961 (5.7) 63 461 (51.6) 18 968 (15.4) 33 634 (27.3) 123 024
Ex-smoker 4501 (5.9) 38 967 (51.0) 12 209 (16.0) 20 682 (27.1) 76 359
Current 1692 (9.6) 10 374 (58.6) 2107 (11.9) 3519 (19.9) 17 692
Missing 59 (8.7) 379 (55.7) 87 (12.8) 155 (22.8) 680
BMI category
<18.5 169 (7.7) 1237 (56.4) 311 (14.2) 477 (21.7) 2194
18.5 to <25.0 3028 (4.2) 34 411 (48.2) 12 398 (17.4) 21 576 (30.2) 71 413
25.0 to <30.0 4110 (5.1) 41 302 (51.2) 12 875 (16.0) 22 427 (27.8) 80 714
≥30.0 4554 (9.3) 28 541 (58.1) 5903 (12.0) 10 123 (20.6) 49 121
Missing 8556 (6.9) 73 141 (58.9) 18 198 (14.7) 24 268 (19.6) 14 313
MOS-PF category
100 2984 (4.0) 29 454 (39.5) 13 001 (17.4) 29 171 (39.1) 74 610
85 to <100 2766 (3.8) 39 937 (55.0) 13 114 (18.1) 16 764 (23.1) 72 581
0 to <85 5790 (11.2) 33 204 (64.4) 5084 (9.9) 7504 (14.6) 51 582
Missing 1352 (9.5) 7690 (53.7) 1884 (13.2) 3387 (23.7) 18 982
Total MVPA, min
0 13 213 (100) 0 0 0 13 213
10-149 0 29 477 (85.6) 1191 (3.5) 3385 (9.9) 34 053
150-299 0 23 758 (67.3) 4082 (11.6) 7462 (21.1) 35 302
≥300 0 59 946 (44.3) 28 098 (20.8) 47 143 (34.9) 135 187
Abbreviations: BMI, bodymass index;
MOS-PF, Medical Outcomes Study
Physical Function scale;
MVPA, moderate to vigorous physical
activity.
a Minutes of vigorous activity
multiplied by 2.
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tivity levels, BMI categories, and participants with and with-
out existing cardiometabolic disease. Meta-analyses have
found that reductions in mortality through physical activity
were significantly higher in women8,26,48 and older people.26
However, these reviews examined the effect of the total
amount of activity rather than that of activity intensity.
Large meta-analyses8,48 of cohort studies have reported
a 29%reduction inmortalitywhencomparinggroupswith the
lowest and highest amount of activity. Our effect sizes for the
protective effect of activity volume against mortality were
larger because we used 0 minutes of MVPA as the reference
category.
A potential explanation for the positive effect of engag-
ing in some vigorous activity on longevity might be that
high-intensity activities lead to more physiologic adapta-
tions, which improve function and capacity. For example,
regular aerobic activities increase cardiac stroke volume and
capillary density, improve endothelial function, and reduce
peripheral resistance, all of which improve the delivery of
oxygen and glucose to tissues.49 Some clinical trials with
equal amounts of physical activity have found that partici-
pants exposed to higher- rather than lower-intensity activ-
ity had more improvements in maximum oxygen consump-
tion, blood pressure, or lipid profiles.14 Similarly, a clinical
trial50 found that, independent of energy expenditure, high-
intensity training was more efficient in achieving anti-
inflammatory effects in patients with type 2 diabetes and
metabolic syndrome.
Table 3. Associations of the Proportion ofWeighted VPAMinutes Among 204 542 Participants of 45 and Up,
2006-2009,With All-CauseMortalitya
Variable
No. of
Participants
MVPA by VPA, %
0% >0% to <30% ≥30%
All sample 204 542 1 [Reference] 0.91 (0.84-0.98)b 0.87 (0.81-0.93)d
All sample (excluding first
year of death)
203 943 1 [Reference] 0.93 (0.85-1.00) 0.88 (0.82-0.94)d
Sex
Men 92 385 1 [Reference] 0.92 (0.84-1.02) 0.86 (0.79-0.94)d
Women 112 157 1 [Reference] 0.89 (0.76-1.01) 0.89 (0.80-0.99)b
Age group, y
45-54 72 211 1 [Reference] 0.92 (0.75-1.13) 0.78 (0.66-0.93)d
55-64 79 215 1 [Reference] 0.95 (0.84-1.09) 0.75 (0.66-0.85)d
65-75 53 116 1 [Reference] 0.84 (0.75-0.94)c 0.97 (0.89-1.06)
MVPA, min/wk
10-149 34 053 1 [Reference] 1.09 (0.84-1.42) 0.76 (0.63-0.92)c
150-299 35 302 1 [Reference] 0.83 (0.67-1.03) 1.03 (0.88-1.20)
≥300 135 187 1 [Reference] 0.90 (0.82-0.98)b 0.85 (0.78-0.92)d
Weight Status
Obese 44 567 1 [Reference] 0.95 (0.81-1.12) 0.86 (0.75-0.99)b
Not obese 159 975 1 [Reference] 0.90 (0.82-0.99)b 0.88 (0.81-0.95)d
CMD
Yes 39 864 1 [Reference] 0.94 (0.83-1.08) 0.91 (0.82-1.02)
No 164 678 1 [Reference] 0.89 (0.81-0.98)b 0.86 (0.79-0.94)d
Abbreviations: CMD, cardiometabolic
disease; MVPA, moderate to vigorous
physical activity; VPA, vigorous
physical activity.
a Minutes of vigorous activity
multiplied by 2.
bP < .05.
c P < .01.
dP < .001.
Test of interactions: CMD P = .86,
obese P = .30, gender P = .73, MVPA
P = .074, age P = .42.
Adjusted for age, sex, education,
marital status, urban/rural residence,
smoking status, weight status,
physical function, alcohol
consumption, fruit and vegetable
intake, and total weighted volume of
MVPA.
Reporting CMD (heart disease,
stroke, thrombosis, diabetes mellitus)
at baseline.
Table 2. Numbers of Deaths and Crude Death Rates Among 217 755 Participants of 45 and Up, 2006-2009, byWeightedMVPAVolume
and the Proportion of Total MVPA as Vigorous Activitya
Total MVPA Time, min/wk
All0 10-149 150-299 ≥300
No.
No.
Who
Died
Crude
Death
Rate, % No.
No.
Who
Died
Crude
Death
Rate, % No.
No.
Who
Died
Crude
Death
Rate, % No.
No.
Who
Died
Crude
Death
Rate, % No.
No.
Who
Died
Crude
Death
Rate, %
NoMVPA NA NA NA NA NA NA NA NA NA NA NA NA 13213 1102 8.34
VPA, %
0 NA NA NA 29477 1465 4.97 23758 826 3.48 59946 2053 3.42 113181 4344 3.84
>0 to
<30
NA NA NA 1191 57 4.79 4082 97 2.38 28098 631 2.25 33371 785 2.35
≥30 NA NA NA 3385 117 3.45 7462 197 2.64 47143 890 1.89 57990 1204 2.08
All 13 213 1102 8.34 34053 1639 4.81 35302 1120 3.17 135187 3574 2.64 217755 7435 3.41
Abbreviations: MVPA, moderate to vigorous physical activity; NA, not applicable; VPA, vigorous physical activity.
a Minutes of vigorous activity multiplied by 2.
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Implications for Physical Activity Guidelines
In the 1970s, physical activity recommendations focusedonly
onvigorous exercise for health benefits.51However, in the en-
suing years, emerging evidence revealed that moderate ac-
tivitieswereassociatedwithsignificanthealthbenefits,52which
led to a paradigm shift, highlighting the benefits ofmoderate
activity.53,54 Current physical activity guidelines in theUnited
States,4 United Kingdom,5 and Australia6 promote the ben-
efits of both moderate and vigorous activities, leaving indi-
viduals tochoose their activitypatternsaccording to theirpref-
erences and abilities.However, emerging evidence, including
findings fromthis study, indicates that independentof thevol-
umeofactivity, engaging insomevigorousactivitymaybeben-
eficial to health and that 2 minutes of moderate activity may
notbeequivalent to 1minuteof vigorous activity.9,21,44,47Wen
et al55 commented that running beats walking by a factor of
2:1 to 4:1 inmortality reduction at iso-volume. Lack of time is
a major barrier to physical activity.56 Because vigorous activ-
ity ismoretime-efficient inachievinghealthbenefits thanmod-
erate activity, promoting vigorous activity might be particu-
larly fruitful for those for whom insufficient time is a major
barrier.
Previous research indicates that it is possible to encour-
age overweightmiddle-agedmen andwomenwith a range of
chronic health problems to safely participate in vigorous ac-
tivity in the form of high-intensity interval training.19 Al-
though vigorous exercise is associated with an increased risk
of cardiovascular events and sudden death, the absolute risk
of death is extremely low (1 sudden death per 1.5 million epi-
sodes of vigorous exertion).57 Therefore, in future activity
guidelines, it may be reasonable to encourage wider consid-
eration of vigorous activities for thosewho are capable of do-
ing soby including statements suchas “If you can, enjoy some
regular vigorous-intensity activity for extra health and fit-
ness benefits” as seen in theNewZealand58 andWorldHealth
OrganizationWestern Pacific Regional guidelines.59
Strengths and Limitations
This prospective study is based on a large sample, with link-
age to death records, and is adjusted for a range of covariates,
particularly total amount of MVPA. One limitation is that we
cannot exclude the possibility that the observed associations
areartifactsofvigorousactivitybeingamarker forgoodhealth.
However,whenwereran theanalyses andexcluded thosewho
died in the first year of follow-up, the resultswere broadly the
same as in thewhole samplewith only a slight attenuation of
the hazard ratio for thosewho reported some vigorous physi-
cal activity.
Weacknowledge that this is anepidemiologic cohort study
and that these findings areobservational.However, given that
it isextremelydifficult (becauseofcompliance,adherence,and
attrition issues) to conduct large long-term randomized clini-
cal trials of different exercise prescriptions and follow-up for
mortality outcomes, this level of evidence is informative and
widely accepted. This type of studyhas beenwidely included
in evidence reviews and is of interest to clinical and exercise
professionals.3 Another limitation is that, typical for large co-
hort studies, all variables were ascertained by self-report and
that there was no distinction between different kinds of vig-
orousactivityoradjustment forage-relatedperceptionsofwhat
constituted vigorous activities.60 On the other hand, vigor-
ous activitieswere themain focusof this study, and these tend
to be better reported than activities of lesser intensity.61 It is
possible that some of themoderate activityminutes reported
byolder participantsmay in fact have beenperformed at light
intensity, and the reporting of vigorous activity time is a bet-
ter self-reportproxyof actually reachinghealth-enhancingen-
ergy-expending thresholds. A further limitation is the lack of
follow-updataonphysical activity. It is, of course,possible that
activity levelsmayhavechangedduring this6-yearperiod, and
if this was the case, then our results would have likely under-
estimated the strengthof theassociationbetweenactivity and
mortality. The study sample tended to oversample thosewho
arehealthier andengaged inhealthier lifestyles (eg, high level
of activity). However, this is of no concern to our study aims
becauseacomparisonwithaNewSouthWalespopulation rep-
resentative sample indicated that although the prevalence of
risk factors differed, estimates of exposure-outcome associa-
tions were almost identical.62 This finding confirms the gen-
eral epidemiologic axiom that relative risks based on internal
comparisons are not dependent on the representativeness of
the cohort.
Future Research Directions
Objectivemeasuresofphysical activitywouldbedesirablebut
are difficult to apply in very large cohort studies.8More stud-
ies are needed that examine the association between differ-
ent combinationsofmoderate andvigorous activitywithmul-
tiplehealthoutcomes,while controlling for theoverall amount
of activity.
Conclusions
Independent of the total amount of physical activity, engag-
ing in some vigorous activitywas protective against all-cause
mortality. This finding applied to both sexes, all age catego-
ries, people with different weight status, and people with or
without cardiometabolic disease. Doing somevigorous activ-
itymightbe important for increasing longevity amongmiddle-
agedandolder adults. If vigorousactivities are consistently in-
dependently associated with health benefits, such activities
should bemore strongly encouraged in activity guidelines to
maximize the population benefits of physical activity.
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